期刊文献+

荷载HO-1基因的脑靶向纳米粒对缺血性脑病大鼠海马神经元的保护作用 被引量:1

Protective efficacy of HO-1 plasmid loaded Lf-PEG-QMC brain targeting nanoparticles on hippocampal neurons in cerebral ischemic injury rats
下载PDF
导出
摘要 目的探讨荷载血红素加氧酶-1(HO-1)基因的乳铁蛋白与聚乙二醇修饰的阳离子壳聚糖(Lf-PEGQMC)纳米粒对缺血性脑病大鼠海马神经元的保护作用。方法将24只SD大鼠随机分为假手术组、缺血性脑病组、缺血性脑病+HO-1基因组(纯基因组)、缺血性脑病+荷载HO-1基因的Lf-PEG-QMC纳米粒干预组(纳米粒组),每组各6只。缺血性脑病组、纯基因组、纳米粒组采用四动脉阻塞法制备缺血性脑病模型,假手术组仅分离而不结扎双侧颈总动脉。缺血性脑病组于缺血15 min后松开血管夹进行再灌注;纯基因组缺血15 min后再灌注时由尾静脉注射HO-1基因质粒20μg/kg;纳米粒组缺血15 min后再灌注时由尾静脉注射荷载HO-1基因的Lf-PEGQMC纳米粒(按基因剂量为20μg/kg给药);假手术组不行再灌注操作。再灌注后第5天将各组大鼠麻醉后取脑组织制作切片,采用HE染色法在倒置显微镜下(×400)检测海马CA1区神经元存活数量,计算神经元存活率。结果假手术组、缺血性脑病组、纯基因组、纳米粒组神经元存活率分别为100%、11.0%、16.6%、57.6%,缺血性脑病组、纯基因组与纳米粒组神经元存活率均低于假手术组(P<0.05),纳米粒组神经元存活率高于缺血性脑病组及纯基因组(P<0.05),纯基因组与缺血性脑病组相比无统计学差异。结论 Lf-PEG-QMC纳米粒能有效携带HO-1基因跨越BBB并在脑组织中表达,有助于HO-1发挥对缺血性脑病海马神经元的保护作用。 Objective To investigate the protective efficacy of HO-1 plasmid loaded Lf-PEG-QMC nanoparticles on the hippocampal neurons of rats with cerebral ischemic injury. Methods A total of 24 adult SD rats were randomly divided into 4 groups: pseudo-operating group,ischemia-reperfusion injury group,ischemia-reperfusion injury + HO-1 plasmid group( plasmid group),andischemia-reperfusion injury + HO-1 plasmid loaded Lf-PEG-QMC nanoparticles group( NPs group). Models of cerebral ischemia were established by the method of four vessels occlusion in ischemia-reperfusion injury group,plasmid group and NPs group. After the common carotid arteries were occluded for 15 minutes,reperfusion was conducted by vein in each group as 20 μg / kg HO-1 plasmids administered in plasmid group,HO-1 plasmid loaded Lf-PEGQMC nanoparticles administered in NPs group. Rats in pseudo-operating group did not adopted the reperfusion. After 5days of ischemia-reperfusion,rats brain in each group were extracted to make histologic sections. The survival statuses of neurons in hippocampal CA1 sector of each rats were detected by HE staining method and to calculate the survival neurons rate. Results The survival neurons rate of pseudo-operating group,ischemia-reperfusion injury group,plasmid group and NPs group was 100%,11. 0%,16. 6%,57. 6%,respectively. The survival neurons rate of ischemia-reperfusion injury group,plasmid group and NPs group was lower than that of pseudo-operating group( P〈0. 05). The survival neurons rate of NPs group was higher than that of ischemia-reperfusion injury group and plasmid group( P〈0. 05). There was no statistic difference between ischemia-reperfusion injury group and plasmid group. Conclusions Lf-PEG-QMC nanoparticles was effective in the transfer of HO-1 plasmid across BBB and it's stable express in brain,which indicates that Lf-PEG-QMC nanoparticles was helpful in the effect of HO-1 on neurons in cerebral ischemic injury.
出处 《山东医药》 CAS 2014年第42期23-26,共4页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81102381 31100762) 江苏省高校自然科学研究资助项目(11KJB310013 13KJB310021) 徐州医学院院长基金资助项目(2012KJZ06)
关键词 纳米粒 血红素氧化酶-1 药物载体 基因治疗 脑缺血 nanoparticles heme oxygenase-1 drug carriers genetic therapy cerebral ischemia
  • 相关文献

参考文献14

  • 1谭春梅,江文宇.脑卒中的预防与控制[J].广西医学,2007,29(1):14-16. 被引量:3
  • 2Sharma G, Modgil A, Layek B, et al. Cell penetraling peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistri- bution and transfection[ J]. J Control Release, 2013,167 ( 1 ) : 1- 10.
  • 3Song YJ, Zong ZM, Liu HZ, et al. Heme oxygenase-1 regulates the JNK signaling pathway through the MLK3-MKK7-JNK3 signa- ling module in brain ischemia injury[ J]. Brain Res, 2012,1429: 1-8.
  • 4Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat [ J ]. Stroke, 1979,10 ( 3 ) :267- 272.
  • 5宋远见,裴冬生,孙亚峰,张芳,张兆成,刘红芝.脑缺血再灌注后依达拉奉联合黄芪对大鼠神经元的保护作用及机制[J].山东医药,2008,48(22):6-8. 被引量:11
  • 6Kaye EM, Sena-Esteves M. Gene therapy for the central nervous system in the lysosomal storage disorders[ J]. Neurol Clin, 2002, 20(3) :879-901.
  • 7Yonemori K, Tsuta K, Ono M, et al. Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer [ J]. Cancer, 2010,116(2) :302-308.
  • 8刘洋,蒋晨.纳米药物递释系统的脑靶向研究进展[J].药学学报,2013,48(10):1532-1543. 被引量:22
  • 9Trapani A, De Giglio E, Cafagna D, et al. Characterization and e- valuation of chitosan nanoparticles for dopamine brain delivery [ J ]. Int J Pharm, 2011,419 ( 1-2 ) :296-307.
  • 10Wohlfart S, Khalansky AS, Gelperina S, et al. Kinetics of trans- port of doxorubicin bound to nanoparticles across the blood-brain barrier[ J]. J Control Release, 2011,154 ( 1 ) : 103-107.

二级参考文献83

  • 1于海宁,张秀清,韩巨,宋云.托吡酯对大鼠局灶性脑缺血再灌注后神经功能及神经元烯醇化酶表达的影响[J].山东医药,2007,47(22):5-6. 被引量:3
  • 2张祥建,许莉,陈左然,刘瑞春.脑心通对大鼠局灶性脑缺血脑组织炎症反应的影响[J].山东医药,2007,47(25):26-27. 被引量:4
  • 3Takagi Y, Nozaki K, Sugino T, et al. Phosphorylation of c-Jun NH (2)-terminal kinase and p38 mitogen-aetivated protein kinase after transient forebraln isehemia in mice[ J]. Neurosel Lett, 2000, 294 (2) : 117-120.
  • 4Gu Z, Jiang Q, Zhang G. Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance[ J]. Neuroreport, 2001, 12(16) : 3 487-3 491.
  • 5Pardridge WM. Drug targeting to the brain [J]. Pharm Res, 2007, 24: 1733-1744.
  • 6Silva GA. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier [J]. Surg Neurol, 2007, 67:113-116.
  • 7Wong HL, Wu XY, Bendayan R. Nanotechnological advances for the delivery of CNS therapeutics [J]. Adv Drug Deliv Rev, 2012, 64: 686-700.
  • 8Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery [J]. Chem Pharm Bull, 2010, 58: 1423-1430.
  • 9Wang J J, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers [J]. hat J Nanomed, 2011,6: 765-774.
  • 10Trapani A, De Giglio E, Cafagna D, et al. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery [J]. lnt J Pharm, 201 I, 419: 296-307.

共引文献33

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部